Global Pharmaceuticals & Biotech High Growth Stocks

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Camurus

Market Cap: SEK 40.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 19.0b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

PharmaEssentia

Market Cap: NT$166.1b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥14.8b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

WuXi XDC Cayman

Market Cap: HK$69.4b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥13.8b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

CorMedix

Market Cap: US$974.9m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

BioGaia

Market Cap: SEK 9.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Krystal Biotech

Market Cap: US$4.2b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Harmony Biosciences Holdings

Market Cap: US$2.1b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥18.6b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

AFT Pharmaceuticals

Market Cap: NZ$272.7m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Genomma Lab Internacional. de

Market Cap: Mex$20.8b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Exelixis

Market Cap: US$10.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Kidswell Bio

Market Cap: JP¥11.8b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Hyphens Pharma International

Market Cap: S$89.6m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

JBM (Healthcare)

Market Cap: HK$2.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

Aarti Drugs

Market Cap: ₹43.9b

Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.

IBN SINA Pharmaceutical Industry

Market Cap: ৳9.5b

Produces and sells pharmaceutical drugs in Bangladesh and internationally.

Neurocrine Biosciences

Market Cap: US$13.2b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Essex Bio-Technology

Market Cap: HK$3.2b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Granules India

Market Cap: ₹111.9b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

Strides Pharma Science

Market Cap: ₹80.8b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

MiMedx Group

Market Cap: US$1.1b

Develops and distributes placental tissue allografts for various sectors of healthcare.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥40.6b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.